These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 3037893

  • 21. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A, Boerrigter G, Costello-Boerrigter LC, Schirger JA, Tsuruda T, Heublein DM, Chen HH, Malatino LS, Burnett JC.
    Circulation; 2004 Apr 06; 109(13):1680-5. PubMed ID: 15023890
    [Abstract] [Full Text] [Related]

  • 22. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M.
    Heart Lung; 1990 Sep 06; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
    Martin FL, Chen HH, Cataliotti A, Burnett JC.
    Rev Cardiovasc Med; 2008 Sep 06; 9(1):39-45. PubMed ID: 18418308
    [Abstract] [Full Text] [Related]

  • 28. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment].
    Cerqueira-Gomes M, Polónia J, Brandão F, Ramalhão C, de Faria DB.
    Rev Port Cardiol; 1989 Feb 06; 8(2):129-48. PubMed ID: 2576635
    [Abstract] [Full Text] [Related]

  • 29. Renal and electrolyte complications of congestive heart failure and effects of therapy with angiotensin-converting enzyme inhibitors.
    Oster JR, Materson BJ.
    Arch Intern Med; 1992 Apr 06; 152(4):704-10. PubMed ID: 1558426
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA.
    Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH, Reams GP.
    J Am Soc Nephrol; 1990 Nov 26; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D, Navis GJ, Donker AJ, de Jong PE.
    J Hypertens Suppl; 1983 Oct 26; 1(1):93-7. PubMed ID: 6100614
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.